Literature DB >> 8593605

Activation of Moloney murine leukemia virus LTR enhances the titer of recombinant retrovirus in psi CRIP packaging cells.

J C Pagés1, N Loux, D Farge, P Briand, A Weber.   

Abstract

The critical physiological function of the long terminal repeat in Moloney murine leukemia virus (MoMLV) gene expression has been thoroughly explored and shown to include binding sites for ubiquitous and tissue-specific transcription factors, such as the glucocorticoid responsive element (GRE) and the LVb sequence recognized by phorbol 12-myristate 13-acetate (TPA)-induced factors. The present study was undertaken to determine the effect of different activators, known to enhance expression of MoMLV, on their ability to modulate retroviral transcripts in psi CRIP producing cell lines. Improvement of recombinant retrovirus production by two psi CRIP producer cells was tested by using dexamethasone, TPA and sodium butyrate (Na-But) alone or in combination. We demonstrate that 5 mM Na-But, or 5 mM Na-But plus 1 microM dexamethasone significantly enhanced viral production. These compounds could induce a 10-fold increase in viral production. There was also a good correlation between the increased viral production and the titer measured after transduction of NIH 3T3. This improvement is of general interest, since a major goal for gene therapy is the production of high retroviral titer for increased transduction efficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593605

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  7 in total

1.  Functional cloning using pFB retroviral cDNA expression libraries.

Authors:  Katherine A Felts; Keith Chen; Kim Zaharee; Latha Sundar; Jamie Limjoco; Anna Miller; Peter Vaillancourt
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.

Authors:  Eric Piver; Christine Collin; Noémie Renault; Thierry Bru; Jean-Christophe Pagès
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

4.  Immortalization of a primate bipotent epithelial liver stem cell.

Authors:  Jean-Etienne Allain; Ibrahim Dagher; Dominique Mahieu-Caputo; Nathalie Loux; Marion Andreoletti; Karen Westerman; Pascale Briand; Dominique Franco; Philippe Leboulch; Anne Weber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

Authors:  Tulin Budak-Alpdogan; Isabelle Rivière
Journal:  Methods Mol Biol       Date:  2009

6.  Expression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging.

Authors:  Yun Mai; Guangxia Gao
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

7.  Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors.

Authors:  Diana E Jaalouk; Milena Crosato; Pnina Brodt; Jacques Galipeau
Journal:  Virol J       Date:  2006-04-07       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.